Boston MedTech Advisors

Boston MedTech Advisors (BMTA) is a regulatory and business consulting firm serving the medical technology industry. Founded in 2006, the firm provides strategic advisory services to established and emerging medtech companies, healthcare providers, entrepreneurs, and investors. BMTA's service portfolio includes market analysis and business strategy development, business development and licensing support, regulatory affairs and quality assurance consulting, clinical study design and management, pricing and reimbursement strategy formulation, and investment support services. The firm leverages over 100 combined years of medtech industry experience to guide clients through complex regulatory, commercial, and market entry challenges. BMTA works with companies across the full product development lifecycle—from early-stage innovation through market launch and post-market compliance. The firm serves as an integrative consulting partner, addressing multiple business elements simultaneously to accelerate time-to-market while maintaining quality and regulatory integrity. BMTA is well-positioned to advise on FDA regulatory pathways, reimbursement strategies, clinical evidence generation, and business model development for a broad range of medical devices and technologies.